| NCT ID | NCT05129150 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Tours |
| Condition | Neurocognitive Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2022-03-31 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2022-03-31 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Following an initial consultation with a memory, resources and research centre (MRRC) doctor, a day hospital may be prescribed to carry out an assessment of cognitive disorders. Patients are then usually followed up in consultation at least once a year, in the framework of a new day hospital and/or consultations with a MRRC doctor.
Eligibility Criteria
Inclusion Criteria: * Patient benefiting from a day hospital at the MRRC of the CHU of Tours for assessment of cognitive functions Exclusion Criteria: * Refusal of TPI ultrasound examination * Patients who opposed to data processing * Patients under judicial protection
Contact & Investigator
Thomas DESMIDT
PRINCIPAL INVESTIGATOR
University Hospital, Tours
Frequently Asked Questions
Who can join the NCT05129150 clinical trial?
This trial is open to participants of all sexes, studying Neurocognitive Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05129150 currently recruiting?
Yes, NCT05129150 is actively recruiting participants. Contact the research team at t.desmidt@chu-tours.fr for enrollment information.
Where is the NCT05129150 trial being conducted?
This trial is being conducted at Tours, France.
Who is sponsoring the NCT05129150 clinical trial?
NCT05129150 is sponsored by University Hospital, Tours. The principal investigator is Thomas DESMIDT at University Hospital, Tours. The trial plans to enroll 300 participants.